Askbio Inc
Clinical trials sponsored by Askbio Inc, explained in plain language.
-
Gene therapy injection aims to strengthen failing hearts
Disease control OngoingThis study tests a single dose of AB-1002, a gene therapy given directly into the heart's arteries, for people with advanced heart failure (NYHA Class III) caused by non-ischemic cardiomyopathy. About 150 adults will be randomly assigned to receive the therapy or a placebo. The g…
Phase: PHASE2 • Sponsor: AskBio Inc • Aim: Disease control
Last updated May 05, 2026 11:55 UTC
-
Gene therapy recipients monitored for lasting effects
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 132 people with Parkinson's disease or multiple system atrophy who previously received AB-1005 gene therapy in earlier trials. Researchers will track participants over time to see how safe the treatment remains and how long its benefits last. The goal is to bet…
Sponsor: AskBio Inc • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
New study maps disease progression to pave way for gene therapy
Knowledge-focused OngoingThis study follows 150 people with early Parkinson's disease or Multiple System Atrophy (a related condition) for up to 18 months. Researchers measure symptoms and biological markers to understand how these diseases progress. The goal is to gather information that will help desig…
Sponsor: AskBio Inc • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC